| 注册
首页|期刊导航|中国当代医药|舒血宁联合脑苷肌肽治疗血管性痴呆的效果观察

舒血宁联合脑苷肌肽治疗血管性痴呆的效果观察

唐敏

中国当代医药Issue(21):81-83,3.
中国当代医药Issue(21):81-83,3.

舒血宁联合脑苷肌肽治疗血管性痴呆的效果观察

Effect observation of shuxuening combined with cerebroside-kinin in the treatment of vascular dementia

唐敏1

作者信息

  • 1. 湖南省祁阳县中医院药剂科,湖南祁阳 426100
  • 折叠

摘要

Abstract

Objective To observe the efficacy of shuxuening combined with cerebroside-kinin in the treatment of vas-cular dementia. Methods Fifty-eight patients with vascular dementia collected from July 2013 to July 2014 in our hospital were randomly divided into observation group receiving shuxuening combined with cerebroside-kinin treatment and control group receiving only cerebroside-kinin treatment.After treatment,the clinical efficacy,MMSS and ADL scores betweeen two groups was observed respectively. Results After treatment,the effective rate of observation group was 89.66%,which was better than the 72.41% of control group,with statistically significant difference (P<0.05).After treatment,MMSE and ADL between two groups increased significantly compared to that before treatment respectively, with statistically significant differences (P<0.05);MMSE and ADL scores of observation group increased significantly compared to that of control group respectively,with statistically significant differences(P<0.05). Conclusion Shuxuening combined with cerebroside-kinin shows good efficacy in the treatment of vascular dementia, thereby of good clinical promotion value.

关键词

血管性痴呆/舒血宁/脑苷肌肽

Key words

Vascular dementia/Shuxuening/Cerebroside-kinin

分类

医药卫生

引用本文复制引用

唐敏..舒血宁联合脑苷肌肽治疗血管性痴呆的效果观察[J].中国当代医药,2015,(21):81-83,3.

中国当代医药

1674-4721

访问量0
|
下载量0
段落导航相关论文